axlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusse

  • SATT AxLR
    • SATT AxLR
    • Governance
    • Services for companies
    • Annual reports
  • Assisting you
    • Researchers
      • Call-for-projects
    • Companies
    • Startups
    • Practical guide
  • Technology offerings
    • Invest
      • In our technologies
      • In our startups
    • Technologies
    • Startups
    • AxLR TV
  • Working with AxLR
    • Purchasing & public procurement
    • Join us
    • Our startups are hiring
  • Media
    • News
    • Agenda
    • Press kit
    • Communication kit
  • Contact
English
  • French
✕
  • Home
  • TESOVIR
GeniaTer-CMT1A
16 June 2020
LRAs
15 June 2020

TESOVIR

TESOVIR

New biomarkers of HIV reservoir : diagnostic and therapeutics

Available technology

Desired partnership(s)

  • Start-Up

IP

  • Patents

Establishment(s)

  • Université de Montpellier
  • CNRS

Laboratory(ies)

  • Institute of Human Genetics (IGH)

Keywords

  • HIV Reservoir
  • Biomarkers
  • mAb

Co-financed by

Context

In HIV patients, after ART (anti-retroviral therapies) treatment is stopped, even for patients with long-time period treatment, a systematic viral rebound is observed. This viral rebound is due to an archived variant. Different cell types are involved in the viral persistence with CD4 T cells being the most important contributors. Today, finding ways to target and destroy latent reservoirs is a major challenge facing HIV researchers. Researchers are exploring different strategies and the identification of specific markers of this reservoir should facilitate the detection of persistently infected cells in patients' samples and in animal models, and represent potential targets for elimination of these cells.

Benefits

The research team has explored biomarkers and identified 2 main biomarkers at the surface of CD4 T cells infected, differentiating latently infected cells from their non-infected counterparts. The project aims at developing tools (for diagnostic and therapy) allowing direct targeting of the reservoirs using the identified biomarkers.

Applications

HIV-1 infection

AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAb

Share
0

Related posts

8 September 2021

StabCFTR


En savoir +
6 July 2021

HTLV-1


En savoir +
23 June 2021

GEOSOTECH


En savoir +
© 2023, AxLR - SATT Occitanie Méditerranée. All rights reserved. | Legal terms & Privacy policy
English
  • English
  • French